2005
DOI: 10.1001/jama.294.2.163
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Vaccines Against Ebola and Marburg Viruses Show Promise in Primate Studies

Abstract: gens that could also be manipulated for use as agents of bioterrorism, the Ebola and Marburg viruses are threats that researchers have sought to overcome for decades.While there are no approved vaccines or therapies against these pathogens and the often fatal hemorrhagic fevers they cause, a report published July 5 in an online edition of Nature Medicine describes new and promising vaccines that appear to offer complete protection for nonhuman primates infected with the viruses (http://www.nature.com /natureme… Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
5
1
0
0

Citation Types

0
2
0
3

Year Published

2006
2006
2020
2020

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations

Cited by 6 publications

(5 citation statements)
references

References 0 publications

0
2
0
3
Order By: Relevance
How this paper cites the one you are viewing
“…Fatal cases are associated with high viremia and defective immune responses, while survival is associated with early and vigorous humoral and cellular immune responses6-9. Although preliminary vaccine trials in primates have been highly successful10-13, no vaccines, specific immunotherapeutics, or post-exposure treatments are currently approved for human use. Since 1994, EBOV outbreaks have increased more than four-fold, thus necessitating the urgent development of vaccines and therapeutics for use in the event of an intentional, accidental or natural EBOV release.…”
mentioning
confidence: 99%
How this paper cites the one you are viewing
“…Fatal cases are associated with high viremia and defective immune responses, while survival is associated with early and vigorous humoral and cellular immune responses6-9. Although preliminary vaccine trials in primates have been highly successful10-13, no vaccines, specific immunotherapeutics, or post-exposure treatments are currently approved for human use. Since 1994, EBOV outbreaks have increased more than four-fold, thus necessitating the urgent development of vaccines and therapeutics for use in the event of an intentional, accidental or natural EBOV release.…”
mentioning
confidence: 99%
How this paper cites the one you are viewing
“…Work with the unsuccessful vaccine candidates (attenuated Venezuelan equine encephalitis virus expressing Ebola glycoprotein and nucleoprotein; recombinant vaccinia virus expressing Ebola glycoprotein; liposomes containing lipid A and inactivated Ebola virus; and concentrated inactivated whole-virion preparation) demonstrated protection against Ebola for mice and guinea pigs, but failed in nonhuman primates [154]. Vaccine against Ebola and Marburg viruses based on recombinant vesicular stomatitis virus has been shown to protect macaques from lethal doses of the corresponding filovirus [155,156].…”
Section: Ebola Virus: Ebola Hemorrhagic Fever
mentioning
confidence: 99%
How this paper cites the one you are viewing
“…Otras enfermedades causadas por los virus son las fiebres hemorrágicas, un grupo de enfermedades causadas por cuatro familias de virus, entre las que se encuentran los virus del Ébola y el Marburg; el virus de la fiebre de Lassa y el virus de la fiebre amarilla (7)(8)(9). Algunas de estas fiebres hemorrágicas causan síntomas leves, pero otras, como las causadas por los virus Ébola y Marburg, causan complicaciones graves en la salud e incluso pueden causar la muerte (8)(9)(10).…”
Section: Introduction
unclassified
“…Por ejemplo, el último y más importante brote de Ébola se presentó en África Occidental en 2014, donde se registraron más de 1000 defunciones; en 2019, se presentaron algunos casos en Europa y en el primer semestre de 2019 se han reportado algunos brotes en el Congo, por lo que se mantiene la alerta mundial. Respecto al virus chikunguña (vchik), llegó desde África a América a finales de 2013 (10,11). De igual manera, al virus del Zika (zikv), también proveniente del África, llegó entre 2015 y 2016 al continente americano y su incidencia alcanzó niveles pandémicos (10)(11)(12).…”
Section: Introduction
unclassified
“…Respecto al virus chikunguña (vchik), llegó desde África a América a finales de 2013 (10,11). De igual manera, al virus del Zika (zikv), también proveniente del África, llegó entre 2015 y 2016 al continente americano y su incidencia alcanzó niveles pandémicos (10)(11)(12).…”
Section: Introduction
unclassified
See 1 more Smart Citation